BioCentury
ARTICLE | Finance

HotSpot heads for clinic with $65M series B round to develop allosteric modulators

With strategics, one crossover on board, HotSpot is likely to raise mezzanine round before exploring IPO

May 21, 2020 11:05 AM GMT
Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article